A People-Driven Research Organization
In the battle for the hearts and minds of young scientists, drug companies are losing out to biotech companies and discovery boutiques. Big pharma needs to attract top talent in much the same way small companies do--creating pathways to allow scientists to achieve their professional and personal aspirations, providing an unmatched research environment, and offering competitive incentives and rewards. Making such opportunities available may push pharma companies beyond their comfort zone, but not making them available will be even worse.
You may also be interested in...
Unique Device Identification (UDI) is key to better transparency and traceability in the EU. But UDI is new to medtech manufacturers and complex. The commission has published some helpful pointers.
Pricing set somewhere down the middle as Moderna reaches deal with US government on initial supplies of its mRNA coronavirus vaccine.
China has shown willingness to go tit-for-tat in its bilateral disputes with the US and the latest comments from US officials show an underlying distrust over clinical data and vaccines safety in China, raising fresh concerns just when collaboration is needed to accelerate availability of the first vaccines in the global pandemic.